Network News

The 2026 Meyenburg Prize goes to bioinformatician and systems biologist Aviv Regev, head of research at the biotech company Genentech in San Francisco, USA. The scientist is considered a pioneer of single-cell genomics, a method that allows for the high-resolution measurement and analysis of gene activity in individual cells—a field of research that has fundamentally […]

Basel, Switzerland / Martinsried, Germany – 28 July, 2026 Celonic AG, a Swiss-based biologics Contract Development and Manufacturing Organization (CDMO), and Leukocare AG, a leading provider of drug product development services, today announced a collaboration to support biopharmaceutical companies developing increasingly complex biologics. The collaboration brings together Celonic’s expertise in cell line development, drug substance […]

At Heidelberg University Hospital (UKHD), there is a new treatment option for certain patients with severe cardiac arrhythmias: an implantable defibrillator in which the electrode—unlike in conventional defibrillators—is placed outside the heart and blood vessels. This protects the blood vessels. In addition, the system can correct some arrhythmias using mild electrical impulses before an electric […]

Certification enables increased support for partners and customers with industry-leading antibody reagents for commercial applications. Danvers, MA, USA, July 16, 2026–Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced that its Beverly, MA, US and Leiden, NL facilities have achieved ISO 13485:2016 certification for […]

Physicist Ulrich Haeberlen contributed to the award-winning “Myon g-2” project through his research. July 16, 2026 An international research group has been awarded the “Breakthrough Prize for Fundamental Physics” for its decades of work on the “Myon g-2” particle physics experiment. Among the 387 laureates is a former researcher at the Max Planck Institute for […]

Ridgefield, CT, USA, July 9, 2026 – BioMed X, a leading innovation engine for pharma, and Boehringer Ingelheim today announced the launch of a new research team at XSeed Labs, the established innovation incubator embedded within Boehringer’s U.S. R&D headquarters in Ridgefield, Connecticut. The newly established research team, Team NIB (New Platform for Next-Generation Intraocular […]

Researchers at Heidelberg University’s Faculty of Medicine are investigating a new care model for older adults with mild strokes at the Heidelberg University Hospital’s Department of Neurology. The Joint Federal Committee (G-BA) is funding the ARTIFICE study with approximately 2.4 million euros. Full Text in German below. Klinische Studie zu leichtem Schlaganfall: stationär oder ambulant […]

Ardigen platform supports VERAXA’s in-house AI capabilities to optimize cancer target pair selection for conditionally active t cell engagers (TCEs) and antibody drug conjugates (ADCs) ZURICH, SWITZERLAND – July 13, 2026 — VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced a collaboration with Ardigen S.A., an AI-driven computational partner for modern […]

Major VectorBee update reflects VectorBuilder’s continued investment in free, researcher-first tools for genetic engineering and vector design. CHICAGO — July 14, 2026 — VectorBuilder, a global leader in gene delivery technologies, is launching a major update to VectorBee, its acclaimed 100% free DNA software created to help researchers view, edit, annotate, and analyze DNA and protein sequences with […]